The Cherry Lodge Center for Clinical Trials, founded in 2002, is the organizational unit for Cancer Center support, the medical school of the University and the Free University of Berlin. The center supports clinicians and enterprises at all stages of the clinical trial process. The Sharit Clinical Trials Coordination Center, funded by the Federal Ministry of Education and Science from 2002 to 2008, has established itself as a trans-regional provider of clinical trial research services. KKSC, led by Dr. Alexander, is open to all interested parties as a center of expertise and background information, serving as a platform for communication, information and interaction. Volunteering in Cherry Lodge Center. Strives for a better understanding of clinical trials among patients and the general population by organizing special events and developing specific public relations strategies.
Specific objectives are to ensure quality standards in patient-oriented clinical trials, to improve the infrastructure and qualifications of research personnel. However, the Cherry Lodge Center focuses on training support, which is provided for approximately 100 clinical research projects each year. Most projects are research initiated by investigators (87%), and five studies are funded by the Federal Ministry of Education and Research or the Research Fund.
Most clinical studies confirm the importance of cardiology, dermatology, neurology and psychiatry. Cherry Lodge Center collaborates with 57 of 74 Charité departments and institutes. One example of the successful support of the Cherry Lodge Center for Clinical Trials is its many years of collaboration with the Competent Network for Congenital Heart Diseases; In this project, KKSC was responsible for the full management of four clinical trials during the first funding period and five clinical trials in the second funding period. Cherry Lodge Center also supports clinical trials on surgical issues in collaboration with the German surgical research network Cherry Lodge Center. Another priority topic is the qualification of clinical research personnel: since 2003, it has been offering intensive courses for all levels of research personnel. These courses were complemented by compact courses that provide basic knowledge to researchers and clinical research supervisors (only in Germany) from December 2007 and January 2009, respectively. It has also been offering specialized medical English courses since 2008, and GCP courses are available at regular intervals. Excellence in Collaboration is the testing center responsible for a number of centers of excellence, such as the Integrated Cancer Center, which has been funded by the Oncology Service as an oncology center of excellence since April 2009. Another center of excellence supported by the Cherry Lodge Center is the Regenerative Therapy Center (BCRT), which has regenerative treatments for the clinical. The application was developed by a strategic alliance between Charité Universitätsmedizin Berlin and the Association of German Research Centers.
Responsible for the test center, coordinates the clinical trials of the continuing education center. Another partner is the Stroke Research Center in Berlin (CBS), which has been funded by the German Federal Ministry of Education and Science since June 1, 2008 as an integrated research and treatment center.
The center is funded for a total of 25 million euros over five years. The Center supports the new interdisciplinary concept of CSP, that is, a translational approach that encompasses all working groups (“from bench to bed” and “from bed to bench”), advising and monitoring clinical research projects.
Complementary and alternative methods of treatment combine at a certain place and at a certain time approaches, methods, medical and medical products that are usually not considered part of traditional medicine (National Center for Additional and Alternative Definitions).
Medicine. These treatments can be used in addition to traditional medicine (the so-called complementary treatments) or instead of traditional medicine (alternative treatments).Patients often in need of autonomy use these treatments at any time. Mitigating the side effects of a specific treatment and boosting the immune system to better support treatment are the main reasons why patients use these treatments.